Ensartinib in the Treatment of ALK Positive or MET Exon 14 Skipping Anvanced Solid Tumors Excluded Lung Cancer
Latest Information Update: 14 Jan 2025
Price :
$35 *
At a glance
- Drugs Ensartinib (Primary)
- Indications Liver cancer; Solid tumours
- Focus Therapeutic Use
- 14 Jan 2025 New trial record